Intracranial mycotic aneurysm

Intracranial mycotic aneurysms, or intracranial infectious aneurysms, describe aneurysms arising from infection of the arterial wall of intracranial vessels.

See mycotic aneurysm for a general discussion on infectious aneurysms.

The epidemiology of intracerebral mycotic aneurysms mirrors that of risk factors, the primary risk factor, accounting for nearly 70% of all cases, being left-sided infective endocarditis 1-4. In patients with infective endocarditis, up to 5% develop intracranial mycotic aneurysms 1,2. Up to 25% of affected patients have more than one intracerebral mycotic aneurysms 1,2.

Unruptured aneurysms present with non-specific clinical features, such as systemic symptoms (e.g. fever, weight loss), headache (localised or generalised), and transient focal neurological deficits from septic microemboli 1-4; very rarely are intracerebral mycotic aneurysms large enough to cause signs and symptoms of mass-effect 5. Ruptured aneurysms present with clinical features of subarachnoid haemorrhage or intracerebral haemorrhage, such as meningism or stroke 1-4.

Intracerebral mycotic aneurysms are nearly always secondary to bacterial infection, however rarely fungal (e.g. neurocandidiasis, CNS aspergillosis) and viral aetiologies (e.g. VZV, HIV-1) have been described 1-6. Viridans group Streptococcus (most common) and Staphylococcus aureus account for up to 90% of all intracranial mycotic aneurysms 1-4.

These aneurysms exist due to infection of the arterial wall 1-4,6. This generally occurs in the context of haematogenous spread from septic emboli to either the artery itself or its vasa vasorum, from which there is bacterial escape into the vessel wall, or in the context of direct bacterial extravascular invasion of the vessel wall 1-4,6. Direct extravascular invasion is rare and occurs in local pathologies (instead of infective endocarditis), such as meningitis, abscess, cavernous sinus thrombophlebitis, or orbital cellulitis 2.

Regardless of aetiology, once bacteria are in the vessel wall, there is a local arteritis resulting in degeneration of the elastic lamina and vessel wall 1-4,6. There is then subsequent formation of pseudoaneurysm through hydrostatic pulsations 1-4,6

Unlike berry aneurysms which are generally located at branch points of large circle of Willis vessels, bacterial intracerebral mycotic aneurysms have a predilection for more peripheral branch points (M2 and beyond), especially in the distal middle cerebral artery 1-4,7. However, up to one-third of all bacterial intracerebral mycotic aneurysms are proximally located, especially in cases of direct extravascular invasion 7,8

In comparison, fungal intracerebral mycotic aneurysms tend to involve long segments of proximal larger circle of Willis vessels, often not involving branching points at all 9. Aneurysms may be larger and more rapidly growing in immunocompromised patients 8.

Intracranial mycotic aneurysms can be evaluated with CT, MRI, or angiography 1-5,9.

Classically, the peripheral location of intracranial mycotic aneurysms allows them to be differentiated from berry aneurysms 1-4, however more proximal aneurysms can be impossible to differentiate from berry aneurysms on any imaging modality 9. Morphologically, these aneurysms are typically small 1-4, although rarely giant intracranial mycotic aneurysms have been described 5, and are typically fusiform (more common), saccular or sacculofusiform 2-4.

CT is often utilised as a first-line imaging modality given its accessibility 1-4,9. Non-contrast studies may show complications of the aneurysm, such as subarachnoid haemorrhage (often convexal), intracerebral haemorrhage (often lobar), abscess, or ischaemic stroke, while the aneurysm may be identified with CT angiography 1-4,9.

MRI has a similar utility to that of CT, however is considered to be slightly more sensitive 1-4,9. Advantages include use of susceptibility-sensitive sequences, such as GRE or SWI, which may reveal evidence of subclinical or asymptomatic bleeding (e.g. microbleeds, cortical superficial siderosis) from ruptured aneurysms, and use of DWI which may show subclinical or asymptomatic ischaemic strokes not visible on CT 10.

Digital subtraction angiography is considered the gold-standard imaging modality for the evaluation of intracranial mycotic aneurysms 1-4,9. In particular, DSA is the most reliable imaging modality for detecting small aneurysms (<3 mm in size) 8.

In addition to management of underlying source of infection, two approaches may be taken 1-4,11:

  • antibiotics alone (conservative approach)
  • antiobiotics combined with a surgical approach

A conservative management approach with antibiotics alone is reserved for cases of unruptured intracranial mycotic aneurysms or in patients not suitable for surgical approaches 1-4. Varying success has been reported using this strategy, with studies consistently finding ~30% of aneurysms disappear, ~20% decrease in size, 15-30% have no significant change in size, and ~20% actually increase in size 1-4. Thus, while this may be an effective approach, serial angiographic follow-up is required to assess efficacy of therapy on aneurysm size 1-4.

Management with antibiotics and surgery is an option for both unruptured and ruptured intracranial mycotic aneurysms 1-4,10. Surgical options include clipping, which was traditionally the favoured approach, or novel endovascular approaches (e.g. endovascular coil embolisation), which are gathering more evidence in recent literature 1-4,11. In recent comparisons, the two surgical techniques have similar outcomes 11.

Even with management, prognosis is poor; unruptured intracranial mycotic aneurysms have a mortality of up to 30%, while ruptured intracranial mycotic aneurysms have a mortality of up to 80% 2. Outcomes are poorer for patients with multiple intracerebral mycotic aneurysms 1.

Intracranial mycotic aneurysms were first described by W S Church, an English physician, in 1869 1,12, with coinage of the term 'mycotic aneurysm' provided by Sir William Osler (1849-1919), a Canadian physician, in 1885 1,13. During this period, 'mycotic' was used to describe all micro-organisms, and thus 'mycotic aneurysm' described any infectious aneurysm - a term which has persisted in medical literature 1.

Stroke and intracranial haemorrhage
Infections of the central nervous system
Share article

Article information

rID: 63362
Synonyms or Alternate Spellings:
  • Intracranial mycotic aneurysms
  • Intracranial infectious aneurysms
  • Cerebral mycotic aneurysms
  • Intracerebral infectious aneurysms
  • Intracerebral mycotic aneurysms
  • Cerebral infectious aneurysms
  • Cerebral infectious aneurysm
  • Intracerebral mycotic aneurysm
  • Intracerebral infectious aneurysm
  • Cerebral mycotic aneurysm
  • Intracranial infectious aneurysm

Support Radiopaedia and see fewer ads

Cases and figures

  • Drag
    Case 1
    Drag here to reorder.
  • Drag
    Case 1: suabarachnoid haemorrhage
    Drag here to reorder.
  • Drag
    Case 2
    Drag here to reorder.
  • Drag
    Case 3: possible
    Drag here to reorder.
  • Updating… Please wait.
    Loadinganimation

    Alert accept

    Error Unable to process the form. Check for errors and try again.

    Alert accept Thank you for updating your details.